| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.01708-07 |
| P8608 | Fatcat ID | release_crvzxluj7vdpbnfnpxrydhalaq |
| P932 | PMC publication ID | 2268468 |
| P698 | PubMed publication ID | 18234796 |
| P50 | author | Jorge G Gomez-Gutierrez | Q79690709 |
| Kelly M. McMasters | Q55615790 | ||
| Xinyu Zheng | Q56995221 | ||
| P2093 | author name string | H Sam Zhou | |
| Hongying Hao | |||
| Xiao-Mei Rao | |||
| P2860 | cites work | Kinase-independent function of cyclin E | Q79544656 |
| The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 | Q24317677 | ||
| Adenovirus E1B 55K represses p53 activation in vitro. | Q24523301 | ||
| Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery | Q24538586 | ||
| CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase | Q24554436 | ||
| Tight control of gene expression in mammalian cells by tetracycline-responsive promoters | Q24564850 | ||
| Human cyclin E, a nuclear protein essential for the G1-to-S phase transition | Q24652527 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Cyclin E in human cancers. | Q27777796 | ||
| Role for a bidentate ribonuclease in the initiation step of RNA interference | Q27860832 | ||
| In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors | Q28240436 | ||
| Pocket proteins and cell cycle control | Q28245850 | ||
| Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast | Q28272102 | ||
| Cyclin E ablation in the mouse | Q28593960 | ||
| Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex | Q29041391 | ||
| The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 | Q29547773 | ||
| Regulation of retinoblastoma protein functions by ectopic expression of human cyclins | Q29618320 | ||
| Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product | Q29620421 | ||
| Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication | Q33649728 | ||
| p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection | Q33785919 | ||
| Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. | Q33785925 | ||
| p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication | Q33814900 | ||
| Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes | Q33880385 | ||
| To cycle or not to cycle: a critical decision in cancer. | Q33957955 | ||
| ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus | Q34115253 | ||
| Replication-selective virotherapy for cancer: Biological principles, risk management and future directions | Q34297058 | ||
| Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts | Q34301861 | ||
| Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein | Q34343950 | ||
| Regulation of cyclin E transcription by E2Fs and retinoblastoma protein | Q34382483 | ||
| An adenovirus mutant that replicates selectively in p53-deficient human tumor cells | Q34399844 | ||
| Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus | Q34469114 | ||
| Cyclin E and cyclin A are likely targets of Src for PDGF-induced DNA synthesis in fibroblasts | Q42810897 | ||
| In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy | Q44269918 | ||
| Structure, DNaseI hypersensitivity and expression of integrated papilloma virus in the genome of HeLa cells | Q44646428 | ||
| S-phase induction by adenovirus E1A requires activation of cdc25a tyrosine phosphatase. | Q44789824 | ||
| Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity | Q45193545 | ||
| Adenovirus with insertion-mutated E1A selectively propagates in liver cancer cells and destroys tumors in vivo. | Q45862986 | ||
| Cyclin E dysregulation and chromosomal instability in endometrial cancer | Q47869187 | ||
| Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor | Q52480364 | ||
| Re-evaluating cell-cycle regulation by E2Fs. | Q53339572 | ||
| Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer. | Q53373554 | ||
| Preparation of poliovirus vaccines in a human fetal diploid cell strain. | Q53438046 | ||
| Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins. | Q53503674 | ||
| Cyclin E is a more powerful predictor of breast cancer outcome than proliferation | Q58188808 | ||
| Gene expression profiles of normal human lung cells affected by adenoviral E1B | Q64377980 | ||
| E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells | Q64379383 | ||
| E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes | Q64379575 | ||
| Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition | Q77310904 | ||
| Stable association of mitotic cyclin B/Cdc2 to replication origins prevents endoreduplication | Q78482184 | ||
| Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection | Q34562704 | ||
| Replication-selective viruses for cancer therapy | Q34563817 | ||
| From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development | Q34577135 | ||
| Manipulation of adenovirus vectors | Q34627721 | ||
| Effects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism. | Q34998360 | ||
| Adenovirus E1A targets key regulators of cell proliferation | Q35260997 | ||
| Replicating adenoviruses in cancer therapy | Q35607472 | ||
| Cyclin E. | Q35775507 | ||
| The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle | Q35875344 | ||
| Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. | Q35883364 | ||
| The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function | Q35991794 | ||
| Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review | Q36147654 | ||
| Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells | Q36246072 | ||
| p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells | Q36328385 | ||
| Cyclin e overexpression reduces infiltrative growth in breast cancer: yet another link between proliferation control and tumor invasion | Q36438500 | ||
| Induction of the cell cycle in baby rat kidney cells by adenovirus type 5 E1A in the absence of E1B and a possible influence of p53. | Q36646330 | ||
| The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs | Q36909556 | ||
| Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis. | Q36914451 | ||
| E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. | Q38317803 | ||
| The zinc finger transcription factor ZFHX1A is linked to cell proliferation by Rb-E2F1. | Q39254725 | ||
| E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest | Q39404546 | ||
| Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway | Q39452818 | ||
| Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. | Q39582723 | ||
| Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein | Q39602482 | ||
| Activation of Adenovirus Early Promoters and Lytic Phase in Differentiated Strata of Organotypic Cultures of Human Keratinocytes | Q39752580 | ||
| Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted | Q39876527 | ||
| Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy. | Q40184003 | ||
| Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells. | Q40341364 | ||
| Adenoviral E1a expression levels affect virus-selective replication in human cancer cells | Q40362547 | ||
| Viral oncoprotein binding to pRB, p107, p130, and p300. | Q40532162 | ||
| E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection | Q40541104 | ||
| Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53. | Q40736238 | ||
| A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors | Q40853518 | ||
| Sensitive assay of RNA interference in Drosophila and Chinese hamster cultured cells using firefly luciferase gene as target | Q40855869 | ||
| Processing of cyclin E differs between normal and tumor breast cells | Q40900933 | ||
| Enhanced expression of p53 in human cells infected with mutant adenoviruses | Q41444438 | ||
| Characterization of the 55K adenovirus type 5 E1B product and related proteins | Q41475587 | ||
| Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system | Q41483751 | ||
| Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. | Q41563742 | ||
| Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis | Q41563751 | ||
| Role of the Rb/E2F pathway in cell growth control | Q41640467 | ||
| Viral transactivating proteins | Q41689449 | ||
| Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation | Q41724590 | ||
| Adenovirus type 5 early region 1B 156R protein promotes cell transformation independently of repression of p53-stimulated transcription | Q41786916 | ||
| Structure and transcription of human papillomavirus sequences in cervical carcinoma cells | Q41914039 | ||
| Cdc42 promotes G1 progression through p70 S6 kinase-mediated induction of cyclin E expression | Q42169248 | ||
| A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. | Q42639115 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 3415-3427 | |
| P577 | publication date | 2008-01-30 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication | |
| P478 | volume | 82 |
| Q28477181 | A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition |
| Q37391112 | Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation |
| Q35488742 | Adenovirus replaces mitotic checkpoint controls |
| Q37539305 | Adenovirus with DNA Packaging Gene Mutations Increased Virus Release |
| Q37645048 | An oncolytic adenovirus that expresses the HAb18 and interleukin 24 genes exhibits enhanced antitumor activity in hepatocellular carcinoma cells |
| Q34048741 | Anti-tumor function of double-promoter regulated adenovirus carrying SEA gene, in the treatment of bladder cancer |
| Q37362758 | Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells |
| Q34238784 | Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma |
| Q33653350 | Developing adenoviral vectors encoding therapeutic genes toxic to host cells: comparing binary and single-inducible vectors expressing truncated E2F-1 |
| Q40695592 | Development of an Oncolytic Adenovirus with Enhanced Spread Ability through Repeated UV Irradiation and Cancer Selection |
| Q35859991 | Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection |
| Q35021632 | Effects of the deletion of early region 4 (E4) open reading frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on virus-host cell interaction, transgene expression, and immunogenicity of replicating adenovirus HIV vaccine vectors |
| Q36387370 | Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus. |
| Q39481837 | Gambogenic acid-induced time- and dose-dependent growth inhibition and apoptosis involving Akt pathway inactivation in U251 glioblastoma cells |
| Q37344472 | Homologous recombination-based adenovirus vector system for tumor cell-specific gene delivery |
| Q34028482 | Indole-3-carbinol (I3C) increases apoptosis, represses growth of cancer cells, and enhances adenovirus-mediated oncolysis |
| Q28486255 | Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E |
| Q26777406 | Oncolytic Replication of E1b-Deleted Adenoviruses |
| Q33906116 | Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles |
| Q35811062 | Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice |
| Q52610258 | Role of Gene Therapy in Pancreatic Cancer-A Review. |
| Q64374652 | Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy |
| Q33931595 | Targeting of p53-transcriptional dysfunction by conditionally replicating adenovirus is not limited by p53-homologues |
| Q40700516 | The Human Adenovirus Type 5 E4orf6/E1B55K E3 Ubiquitin Ligase Complex Can Mimic E1A Effects on E2F. |
| Q37145192 | The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription |
| Q57171688 | The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy |
| Q35058583 | Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter |
| Q39851291 | p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication |
Search more.